Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurovirol ; 10(5): 284-92, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15385251

ABSTRACT

Human immunodeficiency virus type 1 (HIV-1) infection of the brain produces a characteristic disease called acquired immunodeficiency syndrome (AIDS) dementia in which productive infection and inflammatory activation of microglia and macrophages play a central role. In this report, the authors demonstrate that minocycline (MC), a second-generation tetracycline with proven safety and penetration to the central nervous system, potently inhibited viral production from microglia. Inhibition of viral release was sustained through the entire course of infection and even when the drug exposure was limited to the first day of infection. Minocycline was effective even at low viral doses, and against R5- and X4R5-HIV, as well as in single-cycle reporter virus assays. Electrophoretic mobility shift analysis showed that minocycline inhibited nuclear factor (NF)-kappaB activation in microglia. HIV-1 long terminal repeat (LTR)-promoter activity in U38 cells was also inhibited. These results, combined with recently demonstrated in vivo anti-inflammatory effects of MC on microglia, suggest a potential utility for MC as an effective adjunct therapy for AIDS dementia.


Subject(s)
HIV-1/drug effects , Microglia/drug effects , Minocycline/pharmacology , Virus Replication/drug effects , Cell Culture Techniques , HIV Long Terminal Repeat , HIV-1/genetics , HIV-1/physiology , Humans , Microglia/virology , NF-kappa B/metabolism
2.
Brain Pathol ; 12(4): 442-55, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12408230

ABSTRACT

Microglia are endogenous brain macrophages that show distinct phenotypes such as expression of myeloid antigens, ramified morphology, and presence within the neural parenchyma. They play significant roles in a number of human CNS diseases including AIDS dementia. Together with monocyte-derived (perivascular) macrophages, microglia represent a major target of HIV-1 infection. However, a recent report challenged this notion based on findings in SIV encephalitis. This study concluded that perivascular macrophages can be distinguished from parenchymal microglial cells by their expression of CD14 and CD45, and that macrophages, but not microglia, are productively infected in SIV and HIV encephalitis. To address whether parenchymal microglia are productively infected in HIV encephalitis, we analyzed expression of CD14, CD45 and HIV-1 p24 in human brain. Microglia were identified based on their characteristic ramified morphology and location in the neural parenchyma. We found that parenchymal microglia are CD14+ (activated), CD45+ (resting and activated), and constitute approximately two thirds of the p24+ cells in HIV encephalitis cases. These results demonstrate that microglia are major targets of infection by HIV-1, and delineate possible differences between HIVE and SIVE. Because productively infected tissue macrophages serve as the major viral reservoir, these findings have important implications for AIDS.


Subject(s)
AIDS Dementia Complex/immunology , Brain/immunology , HIV-1/immunology , Leukocyte Common Antigens/immunology , Lipopolysaccharide Receptors/immunology , Microglia/immunology , AIDS Dementia Complex/pathology , AIDS Dementia Complex/virology , Adult , Antigens, Surface/immunology , Biomarkers , Brain/pathology , Brain/virology , Cell Size/immunology , Cells, Cultured/cytology , Cells, Cultured/immunology , Cells, Cultured/virology , Female , Fetus , HIV Core Protein p24/immunology , HIV Core Protein p24/metabolism , HIV-1/pathogenicity , Humans , Immunohistochemistry , Macrophages/immunology , Macrophages/pathology , Macrophages/virology , Male , Microglia/pathology , Microglia/virology , Middle Aged , Monocytes/immunology , Monocytes/pathology , Monocytes/virology
3.
Neuropathol Appl Neurobiol ; 28(6): 480-8, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12445164

ABSTRACT

HIV-1 encephalitis (HIVE) is characterized by infection of macrophages and microglial cells, diffuse gliosis, and damage to neuronal populations. The nature of the white matter damage in HIVE remains elusive, and little is known about the status of the oligodendrocyte in HIVE. We have recently described a novel isoform of microtubule-associated protein-2 (MAP2e), which is expressed transiently in developing oligodendrocytes during myelination, and in remyelinating oligodendrocytes in multiple sclerosis lesions. In this study, we tested the hypothesis that MAP2e expression would be increased in the white matter of HIVE. We analysed brain sections from patients with HIVE and controls (HIV+ and HIV-) by immunocytochemistry and found that MAP2e+ cells are significantly increased in HIVE (range, 5-167 cells per cm2) compared to controls (range, 1-25 cells per cm2). MAP2e+ cells were negative for GFAP, CD68, LN3, RCA-1, von Willebrand factor and HIV-1 p24, but positive for MBP or Luxol-Fast Blue, supporting their oligodendroglial lineage. A topographical association between MAP2e and HIV-1 p24 expression was noted, but not between MAP2e and beta-APP, a marker of damaged axons. Our results demonstrate that MAP2e can serve as a marker of white matter damage in HIVE and support the notion that oligodendrocyte damage/repair occurs during HIV-1 infection.


Subject(s)
AIDS Dementia Complex/metabolism , Brain/metabolism , HIV-1 , Microtubule-Associated Proteins/biosynthesis , Oligodendroglia/metabolism , AIDS Dementia Complex/pathology , Adult , Brain/pathology , Female , HIV Seronegativity/immunology , HIV Seropositivity/immunology , Humans , Immunohistochemistry , Male , Middle Aged , Up-Regulation
4.
Glia ; 39(2): 174-83, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12112368

ABSTRACT

Significant numbers of patients with acquired immunodeficiency syndrome (AIDS) develop CNS infection primarily in macrophages and microglial cells. Therefore, the regulation of human immunodeficiency virus type 1 (HIV-1) infection and activation of the brain mononuclear phagocytes subsequent to infection are important areas of investigation. In the current report, we studied the role of granulocyte-macrophage colony-stimulating factor (GM-CSF) and macrophage-CSF (M-CSF) in the expression of antiviral beta-chemokines and HIV-1 p24 in cultures of primary human fetal microglia. We found that stimulation with GM-CSF or M-CSF induced macrophage inflammatory proteins (MIP-1alpha and MIP-1beta) and augmented RANTES expression, after HIV-1 infection of microglia. This was not due to the effect of GM-CSF on viral expression because GM-CSF was neither necessary nor stimulatory for viral infection, nor did GM-CSF enhance the expression of env-pseudotyped reporter viruses. Blocking GM-CSF-induced microglial proliferation by nocodazole had no effect on beta-chemokine or p24 expression. The functional significance of the GM-CSF-induced beta-chemokines was suggested by the finding that, in the presence of GM-CSF, exogenous beta-chemokines lost their anti-HIV-1 effects. We further show that although HIV-1-infected microglia produced M-CSF, they failed to produce GM-CSF. In vivo, GM-CSF expression was localized to activated astrocytes and some inflammatory cells in HIV-1 encephalitis, suggesting paracrine activation of microglia through GM-CSF. Our results demonstrate a complex interplay between CSFs, chemokines, and virus in microglial cells and may have bearing on the interpretation of data derived in vivo and in vitro.


Subject(s)
AIDS Dementia Complex/immunology , Brain/immunology , Chemokines, CC/immunology , Granulocyte-Macrophage Colony-Stimulating Factor/immunology , HIV-1/immunology , Macrophage Colony-Stimulating Factor/immunology , Microglia/immunology , AIDS Dementia Complex/metabolism , AIDS Dementia Complex/virology , Adjuvants, Immunologic/pharmacology , Brain/pathology , Brain/virology , Cell Division/drug effects , Cell Division/immunology , Cells, Cultured , Chemokine CCL3 , Chemokine CCL4 , Chemokine CCL5/immunology , Chemokine CCL5/metabolism , Chemokines, CC/genetics , Chemokines, CC/metabolism , Dose-Response Relationship, Drug , Female , Fetus , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , HIV Core Protein p24/immunology , HIV Core Protein p24/metabolism , HIV-1/drug effects , HIV-1/metabolism , Hot Temperature/adverse effects , Humans , Macrophage Activation/drug effects , Macrophage Activation/immunology , Macrophage Colony-Stimulating Factor/pharmacology , Macrophage Inflammatory Proteins/immunology , Macrophage Inflammatory Proteins/metabolism , Microglia/drug effects , Microglia/virology , Pregnancy , Recombinant Fusion Proteins/drug effects , Recombinant Fusion Proteins/immunology , Virus Replication/drug effects , Virus Replication/immunology
5.
J Neuroimmunol ; 126(1-2): 180-9, 2002 May.
Article in English | MEDLINE | ID: mdl-12020969

ABSTRACT

Astrocytes are important sources of proinflammatory mediators such as iNOS and TNFalpha in the diseased central nervous system. In previous studies, we showed that the cytokine IL-1 plays a critical role in the activation of human astrocytes to express TNFalpha and the inducible form of nitric oxide synthase (iNOS). In the present study, we have addressed the role of the MAP-kinase pathway in the signaling events leading to the induction of these genes. Treatment with SB203580, a specific inhibitor of p38 mitogen-activated protein kinases (MAPK), potently inhibited IL-1-mediated induction of iNOS and TNFalpha in cultures of human fetal astrocytes. In contrast, PD98059, an upstream inhibitor of the extracellular regulated kinase (ERK)1/2 pathway, had little or no effect. Interestingly, SB203580 reduced the mRNA expression for iNOS, TNFalpha, and IL-6, indicating inhibition prior to translation. Transfection of astrocytes with a dominant-negative Jun-NH(2)-terminal kinase (JNK) construct also reduced iNOS expression. Western blot analysis showed phosphorylated p38 and JNK in IL-1-activated astrocytes, and phosphorylated ERK in both resting and activated cells. Electrophoretic mobility shift assay (EMSA) showed that IL-1 induced NF-kappaB and AP-1 DNA complex formation in astrocytes, and that SB203580 inhibited AP-1 complex formation. Taken together, these results demonstrate the differential roles played by the three MAP kinases in human astrocyte inflammatory gene activation and point to a crucial function of p38 and JNK MAP kinases in IL-1-mediated astrocyte activation.


Subject(s)
Astrocytes/enzymology , Astrocytes/immunology , JNK Mitogen-Activated Protein Kinases , Mitogen-Activated Protein Kinases/metabolism , Nitric Oxide Synthase/biosynthesis , Tumor Necrosis Factor-alpha/biosynthesis , Astrocytes/cytology , Cells, Cultured , Enzyme Inhibitors/pharmacology , Fetus/cytology , Flavonoids/pharmacology , Gene Expression Regulation, Enzymologic/drug effects , Gene Expression Regulation, Enzymologic/immunology , Humans , Imidazoles/pharmacology , Interleukin-1/immunology , MAP Kinase Kinase 4 , Mitogen-Activated Protein Kinase Kinases/genetics , Mitogen-Activated Protein Kinase Kinases/metabolism , NF-kappa B/metabolism , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , Nitrites/metabolism , Phosphorylation , Pyridines/pharmacology , Transcription Factor AP-1/metabolism , Transcriptional Activation , Transfection , Tumor Necrosis Factor-alpha/metabolism , p38 Mitogen-Activated Protein Kinases
SELECTION OF CITATIONS
SEARCH DETAIL
...